The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer
Official Title: Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer
Study ID: NCT04670445
Brief Summary: The purpose of this study is to refine and pilot test educational material developed to educate and support patients receiving immunotherapy for advanced cancer. The intervention is an educational video and question prompt list (QPL) to promote communication between patients, caregivers, and the oncology team about the risks and benefits of immunotherapy.
Detailed Description: This two-part study will 1) refine and 2) pilot test an intervention to improve participant's and caregiver knowledge and increase communication with the oncology team about immunotherapy. * The intervention involves watching a video developed to educate patients regarding the risks, benefits, and potential outcomes of immunotherapy treatment and reviewing an immunotherapy-focused QPL prior to ICI initiation. * In Part 1 of this study, investigators will conduct a small open pilot to refine the intervention and study procedures. * In Part 2, investigators will conduct a single-site pilot randomized controlled trial including 130 patients and their caregivers, to evaluate the feasibility of intervention delivery, and the preliminary efficacy of the intervention in improving patient and caregiver knowledge.
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: Yes
Massachusetts General Hospital, Boston, Massachusetts, United States
Name: Laura A Petrillo, MD
Affiliation: Massachusetts General Hospital
Role: PRINCIPAL_INVESTIGATOR